We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHE icon
1926
Chemed
CHE
$6.85B
$618K ﹤0.01%
+1,167
New +$658K
LUNA
1927
DELISTED
Luna Innovations Incorporated
LUNA
$617K ﹤0.01%
285,728
-22,548
-7% -$39.9K
IBRX icon
1928
ImmunityBio
IBRX
$7.24B
$615K ﹤0.01%
+240,311
New +$1M
NJR icon
1929
New Jersey Resources
NJR
$6.11B
$611K ﹤0.01%
+13,101
New +$621K
ITRN icon
1930
Ituran Location and Control
ITRN
$1.09B
$611K ﹤0.01%
19,614
+8,063
+70% +$229K
HTLD icon
1931
Heartland Express
HTLD
$1.06B
$610K ﹤0.01%
+54,406
New +$640K
CWEN icon
1932
Clearway Energy Class C
CWEN
$4.89B
$609K ﹤0.01%
23,418
+16,445
+236% +$455K
BDMDW
1933
CALL
Baird Medical Investment Holdings Warrant
BDMDW
$608K ﹤0.01%
+80,000
New +$3.17K
TFII icon
1934
TFI International
TFII
$12.4B
$607K ﹤0.01%
4,490
-82,539
-95% -$11.7M
PPTA
1935
Perpetua Resources
PPTA
$2.19B
$604K ﹤0.01%
56,593
+12,250
+28% +$126K
EWI icon
1936
iShares MSCI Italy ETF
EWI
$994M
$601K ﹤0.01%
16,713
-18,704
-53% -$697K
NRGV icon
1937
Energy Vault
NRGV
$497M
$599K ﹤0.01%
+262,500
New +$435K
COLM icon
1938
Columbia Sportswear
COLM
$3.29B
$598K ﹤0.01%
+7,122
New +$597K
PCT icon
1939
PureCycle Technologies
PCT
$1.22B
$598K ﹤0.01%
+58,301
New +$676K
BZFD icon
1940
BuzzFeed
BZFD
$102M
$597K ﹤0.01%
+223,578
New +$702K
OSCR icon
1941
Oscar Health
OSCR
$9.37B
$597K ﹤0.01%
44,400
-298,338
-87% -$4.8M
AIA icon
1942
iShares Asia 50 ETF
AIA
$4.43B
$592K ﹤0.01%
8,735
+3,435
+65% +$245K
ARCO icon
1943
Arcos Dorados Holdings
ARCO
$1.76B
$592K ﹤0.01%
81,266
-562,154
-87% -$4.82M
UPLD icon
1944
Upland Software
UPLD
$14.7M
$588K ﹤0.01%
13,543
+9,962
+278% +$323K
CVRX icon
1945
CVRx
CVRX
$132M
$585K ﹤0.01%
46,202
-69,487
-60% -$857K
CERS icon
1946
Cerus
CERS
$591M
$583K ﹤0.01%
378,541
+167,470
+79% +$288K
ARDX icon
1947
Ardelyx
ARDX
$1.25B
$582K ﹤0.01%
+114,819
New +$634K
ASAI
1948
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$580K ﹤0.01%
+129,794
New +$758K
BKE icon
1949
Buckle
BKE
$2.31B
$579K ﹤0.01%
+11,400
New +$539K
RLX icon
1950
RLX Technology
RLX
$2.44B
$578K ﹤0.01%
267,606
+10,071
+4% +$18.1K

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.